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WAVE2 is Regulated by Multiple
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VCA Domain
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The (Wiskott-Aldrich Syndrome Protein)-family verprolin homologous protein
(WAVE) family of proteins occupies a pivotal position in the cell, converting
extracellular signals into the formation of branched ﬁlamentous (F) actin struc-
tures. WAVE proteins contain a verprolin central acidic (VCA) domain at their C-
terminus, responsible for binding to and activating the Arp2/3 complex, which in-
turn nucleates the formation of new actin ﬁlaments. Here we identify ﬁve Casein
Kinase 2 (CK2) phosphorylation sites within the VCA domain of WAVE2, serines
482, 484, 488, 489, and 497. Phosphorylation of these sites is required for a high
afﬁnity interaction with the Arp2/3 complex. Phosphorylation of ser 482 and 484
speciﬁcally inhibits the activation of the Arp2/3 complex by the WAVE2 VCA
domain, but has no effect on the afﬁnity for the Arp2/3 complex when the other
phosphorylation sites are occupied. We demonstrate phosphorylation of all ﬁve
sites on endogenous WAVE2 and show that their mutation to non-phosphory-
latable alanine residues inhibits WAVE2 function in vivo, inhibiting cell rufﬂing
and disrupting the integrity of the leading edge of migrating cells. Cell Motil.
Cytoskeleton 66: 36–47, 2009. ' 2008 Wiley-Liss, Inc.
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INTRODUCTION
The regulated polymerization of actin monomers
into ﬁlaments underlies several cellular processes includ-
ing the protrusion of cell membranes, endocytosis and
the establishment of polarity [Ridley, 2006]. The forma-
tion of new actin ﬁlaments is energetically unfavourable
under cellular conditions. This enables the tight regula-
tion of actin dynamics via a number of catalytic factors
which allow for the spatial and temporal control of F-
actin production [Pollard, 2007]. The ﬁrst of these fac-
tors identiﬁed was the Arp2/3 complex, which stimulates
the formation of branched actin structures seen in the
leading edge lamellipodia of migrating cells [Machesky
et al., 1999].
The Arp2/3 complex is a complex of seven pro-
teins and can itself be activated by interaction with pro-
teins containing verprolin central acidic (VCA) domains.
VCA domains bind both globular actin and the Arp2/3
complex and are thought to stimulate a conformational
change in the quaternary structure of the Arp2/3 complex
[Robinson et al., 2001; Goley et al., 2004; Rodal et al.,
2005]. In this state the Arp2/3 complex could potentially
mimic an actin dimer, overcoming the initial barrier to
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ﬁlament formation and hence create a nucleus supporting
spontaneous elongation by addition of further actin
monomers. Wiskott-Aldrich Syndrome Protein/WASP
family verprolin homologous protein (WASP/WAVE)
proteins are characterized by a C-terminal VCA domain,
preceded by numerous protein domains postulated to
regulate its activity or subcellular localization [Ibarra
et al., 2005]. Thus, WASP/WAVE proteins act as nodes
through which extracellular signals are converted into
the co-ordinated formation of F-actin structures.
There are three mammalian WAVE isoforms.
WAVE2 is essential for life and mediates the formation
of lamellipodia downstream of Rac in murine embryonic
ﬁbroblasts (MEFs) [Yan et al., 2003], as well as regulat-
ing the polarization of the Golgi apparatus downstream
of MAP kinases [Magdalena et al., 2003; Danson et al.,
2007]. The mechanism of WAVE regulation is still not
settled, with several models proposed, including regula-
tion through its interaction with a protein complex con-
taining Nap1, Pir, Abi and HSC300 and/or through bind-
ing IRSp53 [Ibarra et al., 2005]. It is becoming clear that
phosphorylation of WAVE proteins is crucial for their
biochemical and cellular function, with both serine and
tyrosine phosphorylation playing important roles [Leng
et al., 2005; Ardern et al., 2006; Kim et al., 2006; Dan-
son et al., 2007]. We have shown that the activity of
WASP is dependent upon phosphorylation of its VCA
domain by casein kinase (CK2) [Cory et al., 2003], and
others have shown WAVE2 VCA domain phosphoryla-
tion by Erk at two sites [Nakanishi et al., 2007]. We
sought to characterise WAVE2 VCA domain phospho-
rylation more fully and report here the identiﬁcation of
ﬁve phosphorylation sites in the WAVE2-VCA domain.
We found that the previously reported sites were not tar-
gets for Erk, but instead that these and three novel sites
are CK2 targets. We characterise the varying effects of
phosphorylation on the VCA domain’s afﬁnity for and
ability to activate the Arp2/3 complex. By introducing
phospho-deﬁcient mutants into NIH-3T3 cells, we show
that phosphorylation of the WAVE2-VCA domain has
profound effects on its cellular properties.
MATERIALS AND METHODS
Reagents and Cells
NIH-3T3 ﬁbroblasts were grown in DMEM (Invi-
trogen) supplemented with 10% newborn calf serum
(Invitrogen) and pen/ strep. Cos-7 cells were grown with
10% foetal calf serum.
Antibodies
anti-WAVE2 (D16), anti-GST and secondary HRP
linked secondary antibodies were obtained from Santa
Cruz Biotech. Inc. Anti-p34Arc was obtained from
Upstate Biotech. Inc. Anti-FLAG (M2) was obtained
from Sigma. Alexa 568 labelled phalloidin was obtained
from Invitrogen.
Phospho-speciﬁc antibodies were raised against the
phospho-peptides shown in Fig. 2. Peptides correspond-
ing to pser482/4 and pser488/9 were terminated with an
amide. Peptides were conjugated to KLH and used to
immunize rabbits (Eurogentec Ltd.). Serum from the
ﬁnal bleed was clariﬁed by centrifugation at 25,000g for
30 min, and the supernatant was supplemented with 13
TTBS (0.5 M NaCl, 20 mM Tris pH 8.0, 0.1% Tween-
20) and 1% phosphatase inhibitor cocktail 1 (Sigma p-
2850). This was negatively puriﬁed against the non-
phospho peptide coupled to epoxy sepharose 6B
(ES6B)(GE Healthcare). Flow through was passed over
an ES6B phospho-peptide afﬁnity column three times
and washed with TTBS until the ﬂow through had an
OD280 nm < 0.01. Antibody was then eluted with 0.2 M
glycine (pH 2.8) and neutralized with Tris-HCl (pH 8.0).
Expression Constructs
WAVE2-VCA domain (residues 420–498) was
ampliﬁed from human cDNA by PCR and cloned into ei-
ther pEF-Bos downstream of GST or pCMV5 (accession
AF239249) downstream of a FLAG epitope. Point muta-
tions were introduced using the Stratagene Quikchange
method, and sequenced.
Lentiviral vectors were generated by transfer of
EGFP-WAVE2 cDNA into a pSEW sin vector backbone
[Danson et al., 2007]. Virus was produced by co-trans-
fection of 293T cells with this plasmid, and pCMVDR8.91
(packaging plasmid) and pMD.G2 (VSV-G pseudotyping
plasmid), and recovering cell supernatant after 48 h.
Recombinant Protein Production
Cos-7 cells (5 3 106) were electroporated with 10
lg of plasmid in electroporation buffer: (120 mM KCl,
10 mM K2PO4/KH2PO4, pH 7.6, 2 mM MgCl2, 25 mM
Hepes, pH 7.6, 0.5% Ficoll 400) using a Bio-Rad Gene-
pulser at 250 V, 960 lF. After growth overnight COS-7
cells were lysed on ice with lysis buffer:
IGEPAL-630 (1%), 130 mM NaCl, 20 mM Tris-
HCl, pH 8.0, 10 mM NaF, 2 mM sodium orthovanadate,
1% aprotinin, 10 lg/ml leupeptin, 1 mM phenylmethyl-
sulfonyl ﬂuoride, 1 mM EDTA.
Lysates were clariﬁcatied by centrifugation and
incubated with 50 ll glutathione-Sepharose 4B beads at
48C for 2 h. Beads were washed three times with LB,
twice with 0.8 M LiCl, 20 mM Tris-HCl, pH 8.0, and
once with 10 mM Tris-HCl, pH 8.0
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Immunoprecipitation
Endogenous WAVE2 was immunoprecipitated
from 3 3 106 NIH-3T3 cells lysed as above. 5 ll Santa-
Cruz anti-WAVE2 antibody was incubated per sample
for 2 h at 48C, followed by immobilization with 20 ll
Protein A/G sepharose mix, Santa Cruz for a further 2 h.
Beads were washed as above.
Metabolic Labelling
Cos-7 cells were electroporated with GST-VCA or
FLAG-VCA domain constructs as described above. After
growth ovenight, cells were incubated in growth medium
containing 10 Mbq orthophosphate (GE Healthcare) for 3
h, washed and lysed before afﬁnity puriﬁcation.
Phosphatase/ Kinase Reactions
GST pull-downs or WAVE2 immunoprecipitates
were washed in lysis buffer and 0.8M LiCl, 20mM Tris
pH 8.0 prior to incubation with 40 U calf intestinal phos-
phatase (New England Biolabs) for 30 min at 378C in
the manufacturer’s buffer. Following further washing,
precipitates were resuspended with 10 U CK2 (New
England Biolabs) (in 50 mM Tris pH 7.4, 50 mM NaCl,
10 mM MgCl2, 12 lM ATP) or 100 ng recombinant
Jnk2 or Erk2 (Upstate Biotech. Inc.) according to manu-
facturer’s instructions, for 45 min at 378C. These steps
were performed prior to elution of the protein where
required (see below).
Afﬁnity Puriﬁcation
Equal quantities of GST-WAVE2-VCA proteins
attached to glutathione sepharose 4B (GS4B) beads were
washed thoroughly (0.8 M LiCl) to remove interacting
proteins and incubated with fresh lysate from Cos-7 or
U937 cells at the indicated concentration, for 2 h prior to
washing 33 with lysis buffer.
Actin Polymerization Assays
GST-WAVE2-VCA domain was over-expressed in
Cos-7 cells and puriﬁed with glutathione sepharose
beads. Where indicated WAVE2 was treated with calf
intestinal phosphatase (CIP) then CK2 as described prior
to elution three times for 30 min at RT with 200 ll of:
20 mM reduced glutathione, 130 mM NaCl, 50 mM Tris
pH 8.0. Eluates were pooled and dialysed against 10 mM
Tris pH 8, 1 mM EDTA. Protein concentration was esti-
mated using Bradford reagent with BSA as a standard.
Arp2/3 complex, actin and pyrene actin were from
Cytoskeleton Inc. Polymerization assays were performed
in 75 mM KCl, 1mM MgCl2, 1 mM EGTA, 10 mM im-
idazole, pH 7.0 with 10 nM Arp2/3 complex and 2.5 lM
actin (0.125 lM) pyrene actin), pre exchanged with
200 lM ATP. Fluorescence was measured using excita-
tion of 365 nm and emission at 405 nm.
Rufﬂing
NIH-3T3 cells were infected with lentivirus con-
taining cDNA for EGFP-WAVE2 with a multiplicity of
infection of one, as calculated using titrations of NIH-
3T3 cells. After 48 h cells were washed and grown on
for 1 week prior to freezing. Aliquots were thawed and
grown further prior to seeding onto coverslips (coated
with poly-L-lysine followed by ﬁbronectin 12.5 lg/ml)
in medium containing 0.5% serum at 60% conﬂuence.
After 24 h cells were stimulated with platelet-derived
growth factor (PDGF) bb (Upstate Biotechnology Inc.)
at 1 ng/ml for 25 min then ﬁxed and stained with phalloi-
din. Cells with one or more F-actin rich rufﬂe were
scored. Data were obtained from three separate experi-
ments each counting 5 or 10 ﬁelds per condition.
Scratch-Wounding
Lentivirally infected cells (see above) were seeded
into 4-well glass chambers as described [Danson et al.,
2007]. Wounds were generated using a 0.5 mm point,
and cells tracked as described [Danson et al., 2007].
Leading edges were analyzed after 7.5 h. Movie
stills were taken and the ratio between the wound perim-
eter and the straight line distance calculated to give an
indication of raggedness. Data were gathered from three
separate experiments with 20 wound edge ﬁelds per con-
dition analyzed in total.
Statistics
Data were analyzed using Graphpad Prism soft-
ware and Fisher’s exact test (rufﬂing), and ANOVA (per-
sistence and raggedness) as detailed in the ﬁgure
legends.
RESULTS
Phosphorylation of the WASP-VCA domain by
CK2 has marked effects on its Arp2/3 complex binding
and activation properties [Cory et al., 2003]. We noted
that the WAVE2-VCA domain also contains several
potential CK2 sites (Fig. 1A) and were interested to
know if phosphorylation of this region inﬂuenced its
actin nucleation activity.
The WAVE2-VCA Domain Is Phosphorylated
on Five Residues
We noted that the GST-tagged WAVE2-VCA
domain puriﬁed from Cos-7 cells migrated faster on
SDS-PAGE following treatment with CIP (Fig. 1B),
indicating the presence of one or more phosphates. Three
residues within the WAVE2-VCA domain fall within the
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strictest CK2 consensus sequence of ser/thr-X-X-asp/glu
[Kuenzel et al., 1987; Meggio and Pinna, 2003], namely
ser482, ser484, and ser489, making them candidates for
phosphorylation. Individual mutations of these residues
to a non-phosphorylatable alanine did not noticeably
alter the mobility of the VCA domain on SDS-PAGE.
However, dual mutation of ser482 and ser489 markedly
increased the mobility of the VCA domain (Fig. 1B). As
the mobility was not increased further by CIP treatment,
it appears that phosphorylation of ser482 and ser489 is
responsible for the mobility shift. However, as not all
phosphorylation events alter protein mobility, we also
looked at the incorporation of radiolabelled phosphate
into the WAVE2-VCA domain using metabolic label-
ling. While mutation of ser484 to alanine had no effect
on mobility of the WAVE2-VCA domain, it did reduce
incorporation of 32P when mutated in addition to the
dual ser482/489 ala mutation (Fig. 1C), suggesting it is
also a phosphorylation site. Additional mutation of the
remaining serine residues within the WAVE2-VCA do-
main—ser488 (4A mutant) and ser497 (5A mutant)—
also cumulatively reduced incorporation of phosphate
(Fig. 1D), indicating that all ﬁve serine residues within
the acidic region of the WAVE2-VCA domain are poten-
tial phosphorylation sites.
Endogenous WAVE2 Is Phosphorylated
Within the VCA Domain
To determine whether the ﬁve serine residues iden-
tiﬁed above were true phosphorylation targets, we raised
antibodies against the appropriate phospho-peptide
sequences (Fig. 2A). Due to their close proximity, dou-
bly phosphorylated peptides were used to generate anti-
bodies against p482/p484 and p488/p489. All antibodies
recognized wild type GST-WAVE2-VCA domain fusion
proteins puriﬁed from Cos-7 cells, but had no reactivity
against phosphatased forms or GST (Fig. 2B). Mutation
of target residues also prevented reactivity, demonstrat-
ing that the antibodies are both phospho- and site
speciﬁc. As expected, the p488/p489 antibody had full
reactivity with the dual WAVE2-VCA ser482/ser484ala
mutant, but it still retained some reactivity following fur-
ther mutation of ser489ala in a triple mutant (Fig. 2B,
lane 3A). This was lost following further mutation of
ser488 ala, demonstrating an absolute requirement for
phosphorylation of ser488 and a partial requirement for
phosphorylation of ser489 for reactivity.
WAVE2 immunoprecipitates from NIH-3T3 cells
were detected by all antibodies (Fig. 2C), showing that
WAVE2 is phosphorylated on these sites in vivo (with
the caveat regarding ser489 discussed above).
CK2 and Not MAP Kinases Phosphorylate the
WAVE2 VCA Domain
A recent report claimed that WAVE2 ser482 and
ser484 are targets for Erk2 in vitro [Nakanishi et al.,
2007]. We thought this unlikely (1) due to the lack of an
Erk consensus sequence S/T-P and (2) due to the homol-
ogy of these residues with the CK2 sites in the WASP-
VCA domain [Cory et al., 2003], a fact overlooked by
the authors. We found that dephosphorylated WAVE2
immunoprecipitates could be restored to endogenous lev-
els of phosphorylation by CK2 treatment (Fig. 2C).
Next, we puriﬁed GST-WAVE2-VCA domain from
Cos-7 cells and treated it with CIP. In vitro kinase assays
were performed with CK2, Erk2 or Jnk2 and samples
were immunoblotted with phospho-speciﬁc antibodies.
CK2 treatment led to phosphorylation at all ﬁve sites,
whereas Erk or Jnk treatment did not phosphorylate any
(Fig. 2D). Erk and Jnk were shown to be functional by
parallel assays demonstrating their ability to phosphoryl-
ate sites in the poly-proline rich region of a GST-
WAVE2 fusion protein [Danson et al., 2007] (Fig. 2E).
WAVE2 Is Constitutively Phosphorylated In Vivo
We have used our phospho-speciﬁc antibodies to
monitor levels of phosphorylation of endogenous
WAVE2. We ﬁnd that WAVE2 is constitutively phos-
phorylated in the VCA domain in all conditions
Fig. 1. The WAVE2 VCA domain is phosphorylated on multiple
serines. A: Alignment of the C-termini of human WASP and WAVE2.
Bold residues indicate known phosphorylation sites (WASP) and
potential sites (WAVE2) in the acidic region. B: GST-WAVE2 VCA
domains were puriﬁed from Cos-7 cell lysates, treated with phospha-
tase (CIP) as indicated and resolved by SDS-PAGE. WT 5 wild-type,
numbers indicate serine residues mutated to alanine. C: GST-WAVE2
VCA domains were metabolically labelled in Cos-7 cells, puriﬁed and
analyzed by auto-radiography. D: FLAG tagged WAVE2 VCA
domains were metabolically labelled in Cos-7 cells and analyzed as
indicated. 3A 5 482A 1 484A 1 489A; 4A 5 3A 1 488A; 5A 5 4A
1 497A.
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tested, including serum starvation/ stimulation, growth
factor stimulation and scratch wounding among others
(data not shown). WAVE2 isolated from NIH-3T3
cells cannot be further phosphorylated on the VCA
domain by CK2 treatment (Fig. 2C) suggesting that a
large proportion of cellular WAVE2 is phosphorylated
in the VCA domain, similar to WASP [Cory et al.,
2003], indicating the constitutively active nature of
CK2. However, in contrast to WASP we are unable to
inhibit this phosphorylation using CK2 inhibitors, de-
spite a reduction of N-WASP phosphorylation at its
CK2 dependent VCA domain phosphorylation site
(Fig. 3B). A panel of other kinase inhibitors
(including PI3 kinase and MAP kinase inhibitors)
have been tested under a variety of conditions and
have also failed to reduce WAVE2-VCA domain
phosphorylation (Fig. 3 and data not shown). The rea-
son for this resistance to CK2 inhibitors is unclear but
it may reﬂect the existence of an inaccessible pool of
CK2, a very long-lived and stable phospho-protein
species or the involvement of a distinct kinase, resist-
ant to the inhibitors tested. It is also possible that
there are spatial, temporal or signal dependent changes
in WAVE2 VCA domain phosphorylation that we are
unable to detect using our methodology.
Multiple Phosphorylation Increases the Afﬁnity
of the VCA Domain for the Arp2/3 Complex
VCA domain binding to the Arp2/3 complex
occurs through residues within the central (C) and acidic
(A) regions of the VCA domain [Marchand et al., 2001;
Panchal et al., 2003]. Wild type WAVE2-VCA domain
puriﬁed from Cos-7 cells was highly phosphorylated
within the VCA domain (see Fig. 2) and bound the Arp2/
3 complex from fresh cell lysates (Fig. 4A). Phosphatase
treatment of the WAVE2-VCA drastically reduced the
amount of Arp2/3 complex bound. The role of phospho-
rylation was conﬁrmed by the ﬁnding that binding could
be restored by CK2 treatment (Figs. 4A and 4B). We
found in contrast to the ﬁndings of Nakanishi et al. that
Fig. 2. The WAVE2 VCA domain is phosphorylated by CK2. A:
phospho-peptides used to generate antibodies. pS indicates phospho-
serine. B: GST-WAVE2 VCA domains were puriﬁed from Cos-7 cells
and treated with CIP where indicated. Numeric lane descriptors (left
panel) indicate residues mutated to alanine, or additive mutants (nA)
as described in legend to Fig. 1. Antibodies used for immuno-blotting
are indicated on the right of relevant panel. C: Endogenous WAVE2
was immuno-precipitated from NIH-3T3 cells and treated with CIP /
CK2 as indicated, before immuno-blotting. D: WAVE2 VCA domains
were puriﬁed from Cos-7 cells and treated with CIP / kinase as indi-
cated before immuno-blotting. E: Fusion proteins were puriﬁed from
Cos-7 cells and treated with CIP / kinase as a control for kinase
activity.
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WAVE2-VCA domains bearing a double alanine muta-
tion at sites 482 and 484 showed no reduction in afﬁnity
for the Arp2/3 complex (Figs. 4A and 4B). Instead, cu-
mulative mutation of the phosphorylation sites within
the VCA domain lead to a decrease in the afﬁnity for the
Arp2/3 complex (Fig. 4A). We could not attribute this
decrease in binding to phosphorylation of any speciﬁc
residues as independent alanine substitutions at 482 1 4,
488 1 9, and 497 all bound the Arp2/3 complex with
similar afﬁnity over a range of concentrations (Fig. 4B).
Binding to G-actin is independent of the phosphorylation
state of the VCA domain (Fig. 4A). This would be
expected as the G-actin binding V region lies N-terminal
to the CK2 phosphorylation sites [Kelly et al., 2006].
Phosphorylation Inhibits the Activity of the
WAVE2-VCA Domain
The effect of phosphorylation on the activity of the
WAVE2-VCA domain was tested using in vitro poly-
merization assays. Wild type (phosphorylated) GST-
WAVE2-VCA domains isolated from Cos-7 cells were
inactive in these assays, and were unable to stimulate the
Arp2/3 complex (Figs. 4C and 4D). Higher concentra-
tions (>100 nM) of WT-WAVE2 VCA were unable to
stimulate the Arp2/3 complex (data not shown). How-
ever, dephosphorylation resulted in an active VCA do-
main, capable of stimulating the Arp2/3 complex to nu-
cleate branched actin structures, suggesting an inhibitory
role for phosphorylation (Fig. 4C). Use of VCA domain
point mutants, revealed that prevention of phosphoryla-
tion of ser482 and ser484, but not the other sites, leads to
activity akin to the dephosphorylated protein, suggesting
that ser482 and ser484 phosphorylation by CK2 is inhibi-
tory. Mutation of ser488 and ser489 together or ser497
alone resulted in an inactive VCA domain (ie compara-
ble to the activity of wild-type VCA domain), showing
that their phosphorylation is not inhibitory. Treatment of
dephosphorylated wild type VCA domain protein with
CK2 caused reversion of the VCA domain to an inactive
form, whereas treatment of the ser482/484 ala mutant
with CK2 does not suppress its activity (Fig. 4D), con-
ﬁrming that inhibition by CK2 is speciﬁc to phosphoryla-
tion of these residues. A ser482/484/488/489 ala quadru-
ple mutant in which only ser497 is phosphorylated
showed no increase in activity over the 5A mutant (ie. in
the absence of inhibitory ser482/484 phosphorylation,
data not shown). This shows that the increase in afﬁnity
for the Arp2/3 complex in the 4A mutant compared to
the 5A (Fig 4A) does not enhance the ability of the VCA
domain to stimulate Arp2/3 complex function, in line
with the studies divorcing the afﬁnity from the efﬁcacy
of Arp2/3 complex activation [Panchal et al., 2003].
Phosphorylation and Cellular Function of WAVE2
We were interested to know whether VCA domain
phosphorylation was required for the cellular function of
WAVE2. PDGF stimulation of ﬁbroblasts results in the
formation of both peripheral and dorsal (circular) rufﬂes,
a process thought to rely on WAVEs [Suetsugu et al.,
2003; Yan et al., 2003]. Imaging of the actin cytoskele-
ton with ﬂuorescently labelled phalloidin revealed a pre-
dominance of circular rufﬂes that form on the dorsal sur-
face of the cells upon PDGF stimulation. There were
also some cells that exhibited small peripheral rufﬂes.
We found that low-level expression of a dominant nega-
tive GFP-WAVE2 construct lacking its VCA domain
signiﬁcantly inhibited rufﬂe formation in response to
PDGF (Fig. 5) whereas wild type GFP-WAVE2 or a
green ﬂuorescent protein (GFP) control did not. Intro-
duction of GFP-WAVE2 5A also inhibited rufﬂe forma-
tion (Figs. 5A–5C), indicating that phosphorylation of
the VCA domain is required for its cellular function, and
that in its absence, WAVE2 expression exerts apparently
dominant negative effects. We next looked at the effects
Fig. 3. Effect of inhibitors on endogenous WAVE2. NIH-3T3 ﬁbro-
blasts were starved by plating in 0.5% calf serum and incubating over-
night. The indicated inhibitors were added to the culture medium for
3 h prior to stimulation with 10% serum for 7 min where indicated. A:
Cells were lysed and WAVE2 immunoprecipitated. Samples were
split in three and immunoblotted with phospho-speciﬁc antibodies.
Blots were stripped and reprobed for WAVE2 showing equal loading
(the pp488/9 blot reprobe is shown here. The others showed similar
loading but are omitted for clarity). Lysates were probed with phos-
pho-Erk antibodies (pERK), stripped and reprobed with antibodies for
total Erk (tot. ERK). B: As A except lysates were blotted for SK896, a
phospho-speciﬁc antibody recognizing CK2 dependent phosphoryla-
tion of N-WASP [Cory et al., 2003]. Tubulin blots were used as a
loading control. The top two panels show WAVE2 and pp482/4 im-
munoblots of immunoprecipitates from cells incubated with DMSO
(2) or the CK2 inhibitor DRB, prior to stimulation with serum.2 5
DMSO (1/1000) vehicle; SP 5 SP600125 (20 lM) JNK pathway in-
hibitor; Uo 5 Uo126 (10 lM) ERK pathway inhibitor; DRB 5 5,6-
dichloro-1-b-D-ribofuranosylbenzimidazole (50 lM) CK2 inhibitor;
DMAT 5 2-dimethylamino-4,5,6,7-tetra-bromo- benzimidazole (20
lM) CK2 inhibitor; LY5 LY294002 (20 lM) PI3 kinase and CK2 in-
hibitor; Wt. 5 wortmannin (100 nM) PI3 kinase inhibitor; D4476 5
4-(4-(2,3-Dihydrobenzo[1,4]dioxin-6-yl)-5-pyridin-2-yl-1H-imidazol-
2-yl)benzamide (50 lM) CK1 inhibitor.
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of cumulatively mutating the VCA domain phosphoryla-
tion sites on the effect of WAVE2 transgene expression
on rufﬂe formation. A dual mutation of ser482/4 ala
(2A), had no signiﬁcant effect on rufﬂe formation,
whereas the 4A and 5A mutants did show signiﬁcant in-
hibition of rufﬂe formation in response to PDGF (Figs.
5D and 5E). These ﬁndings suggest that the phospho-de-
pendence of the afﬁnity of the WAVE2 VCA domain for
the Arp2/3 complex may be important for WAVE2 func-
tion in vivo. These data extend the ﬁndings of Nakanishi
et al, who show that a 2A mutant was adept at restoring
rufﬂe formation in WAVE2 null ﬁbroblasts [Nakanishi
et al., 2007]. We ﬁnd that WAVE1 is upregulated in
NIH-3T3 cells following WAVE2 siRNAi treatment
(data not shown), making attempts to study the ability of
the transgene to rescue cells with knocked-down
WAVE2 levels difﬁcult to interpret.
In order to induce the formation of peripheral cell
protrusions (or lamellae) we performed scratch-wound-
ing assays on conﬂuent monolayers of NIH-3T3 cells
which respond by extending lamellae into the wound
space, followed by migration towards the opposing
wound edge. We observed that the wound edge was con-
siderably more ragged in appearance following expres-
sion of either delta VCA or 5A WAVE2 (Figs. 6A and
6C). This was quantiﬁed by dividing the straight-line
distance between the edges of a wound by the total
perimeter distance or ‘coastline’ of the wound edge (Fig.
Fig. 4. Phosphorylation controls biochemical functions of the
WAVE2 VCA domain. A: GST WAVE2 VCA domains containing
the indicated mutations, were puriﬁed from Cos-7 cells. WT VCA
domains were treated with phosphatase (CIP) or CIP and CK2 where
indicated prior to incubation with fresh U937 cell lysate at 0.7 mg/ml
protein. G 5 GST alone pull-down. Pull-downs were immuno-blotted
for p34Arc, actin or GST as shown. Arrow head indicates degradation
products. B: As A, except double and single alanine mutants were
incubated with Cos-7 cell lysate (lys) at the indicated concentrations
(C, D) Actin polymerization assays performed with GST-WAVE2
VCA domains as indicated.
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Fig. 5. WAVE2 phosphorylation is required for rufﬂe formation.
Phosphorylation of the WAVE2 VCA domain is required for the for-
mation of PDGF-stimulated rufﬂes. A: NIH 3T3 cells expressing
GFP-full length WAVE2 transgenes were plated onto ﬁbronectin-
coated glass coverslips with or without stimulation with PDGF-BB
(1 ng/ml) for 25 min prior to ﬁxation with 4% formaldehyde and stain-
ing with Alexa568 phalloidin and DAPI. Images are maximum projec-
tions of confocal stacks of 10 slices. Scale bars 10 lm. B: Quantiﬁca-
tion of 3 independent rufﬂing experiments, for each of which, 10 ﬁelds
were imaged per cell type, per condition (1/- PDGF) DV 5 GFP-
WAVE2DVCA. C: Representative immunoblots of PDGF rufﬂing
experiments demonstrating relative transgene expression levels: trans.
refers to transgenic WAVE2, endog. to endogenous WAVE2. D: As
B, except ﬁve ﬁelds imaged per cell type, 2A 5 GFP-full length
WAVE2 ser482/4AA, 4A 5 2A 1 488/9AA mutation, 5A 5 4A 1
497A mutation. E: western blot analysis of transgene expression in
NIH-3T3 cells used for the analysis in D. Statistics are the results of
performing a Fishers exact test using GraphPadPrism software. ns 5
not signiﬁcant.
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6B). This analysis revealed a signiﬁcant increase in rag-
gedness caused by WAVE2 5A expression (Fig. 6D)
suggesting that the integrity of the leading edge had been
compromised and that formation of lamellipodia had
been disrupted. Knock-down of WAVE2 has been shown
to decrease the persistence of migration direction
[Danson et al., 2007], providing another means to test
the importance of VCA domain phosphorylation. We
observed that low level expression of GFP-WAVE2 5A
caused a slight but signiﬁcant reduction in the persist-
ence of migration (Fig. 7A), with wound edge cells dis-
playing frequent changes in direction compared to GFP-
WAVE2-WT expressing cells or GFP controls (Fig. 7B).
Overall migration speed was not affected (Fig. 7C).
These data are consistent with the PDGF rufﬂing experi-
ments and demonstrate a requirement for phosphoryla-
tion of WAVE2 for it to contribute to cell protrusion.
DISCUSSION
In this paper we show that WAVE2 is subject to
multiple functional phosphorylation events within its
VCA domain. As the VCA domain is the key output
Fig. 6. Disruption of leading edge integrity in cells expressing VCA-
phospho-deﬁcient WAVE2. A: Scratch wound healing assays reveal a
requirement for WAVE2 phosphorylation in the maintanence of a
intact leading edge. Conﬂuent monolayers of lentivirally-infected NIH
3T3 cells expressing the indicated GFP-WAVE2 transgenes were
scratched and phase images taken at 7.5 h. Scale bars 40 lm. B: Illus-
tration of the method used to quantify the wound length ratio, the
ragged line is the wound perimeter and the straight line the straight
line wound lenth. C: Representative wound perimeter measurements
from all 4 cell types. D: Quantiﬁcation of three separate experiments,
n 5 20 wound edges. *** 5 P < 0.001, ** 5 P < 0.01. Statistics
refer to a one-way ANOVA test with Newman-Keuls post test. Error
bars represent standard error of the mean. E: Expression analysis of
conﬂuent monolayers without and without scratching.
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domain of WAVE family proteins, these phosphoryla-
tions are well positioned to acutely inﬂuence binding af-
ﬁnity for and activation of the Arp2/3 complex.
Two other reports of VCA domain phosphorylation
have been published. A recent paper identiﬁed ser482
and ser484 as in vitro targets for Erk2, despite the ab-
sence of a proline in the 11 position [Nakanishi et al.,
2007], generally regarded as the minimal consensus
sequence for this kinase [Shaul and Seger, 2007]. Our
use of gel shift analysis and phospho-speciﬁc antibodies
demonstrates a high stoicheometry of phosphorylation
by CK2, whereas Nakanishi et al. rely on incorporation
of radiolabelled phosphate, which while demonstrating
phosphorylation of the VCA domain gives no indication
of the stoicheometry. We were unable to show any
phosphorylation of the WAVE2 VCA domain using
Fig. 7. Decrease in migration persistence in cells expressing VCA-
phospho-deﬁcient WAVE2. A: Traces of cell paths from one repre-
sentative experiment. Cells expressing the indicated transgenes were
grown to conﬂuence and scratch wounds made. Cells at the leading
edge of a wound edge were tracked every 30 min for the 6 h preceed-
ing wound closure using ImageJ software. The starting point of each
track was normalized to 0 and aligned so the x-axis represents the
wound edge. B: Persistence of migration calculated by dividing the
length of the cell path by the straight-line length. Statistics were per-
formed on data from three replica experiments using GraphPad Prism
software to perform a one-way ANOVA test followed by a Newman-
Keuls post-test. ** 5 P < 0.01. C: Speed of migration obtained from
tracking showed no signiﬁcant difference between conditions. All
error bars represent standard error of the mean. In both B and C, a
lack of statistical comparisons between datasets indicates a P > 0.05.
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recombinant Erk2, and suggest that the results of Naka-
nishi et al may reﬂect a contaminant in their Erk2 prepa-
ration or extended incubation times. In addition, the
phosphorylated residues we have identiﬁed comply
largely with established CK2 consensus sequences
[Kuenzel et al., 1987; Meggio and Pinna, 2003], and
complement an earlier study of phosphorylation of the
WASP VCA domain by CK2 [Cory et al., 2003].
In addition to ser482 and ser484 we have used
phospho-speciﬁc antibodies to identify ser487, ser488,
and ser497 as true in vivo phosphorylation sites in
WAVE2. Our results suggest that multiple phosphoryla-
tion of the WAVE2-VCA domain is required for high
afﬁnity binding to the Arp2/3 complex. Abolition of
ser482 and ser484 phosphorylation, did not affect the
afﬁnity of the interaction when the other phosphorylation
sites were occupied, despite the inhibitory effect of phos-
phorylation of ser482 and 484 on the activity of the
VCA domain. The lack of correlation between the afﬁn-
ity of a VCA domain for the Arp2/3 complex and its ac-
tivity has long been established, suggesting the presence
of a two step mechanism [Marchand et al., 2001; Panchal
et al., 2003; Beltzner and Pollard, 2008]. Our data on the
afﬁnity of the VCA domain for the Arp2/3 complex cor-
relate with work showing that regions of the WAVE1
VCA domain equivalent to ser488 and ser497 form con-
tacts with the Arp2/3 complex whereas ser482 and
ser484 do not [Panchal et al., 2003; Kelly et al., 2006].
Hence, phosphorylation of these residues in WAVE2
could potentially affect the binding interface.
In contrast to the ﬁndings with WASP we do not
detect any effect of VCA domain phosphorylation on the
activity of the full length WAVE2 protein in vitro (data
not shown). Like WASP, the full length WAVE2 protein
is considerably more active than the isolated VCA
domain [Cory et al., 2003] and our unpublished data,
suggesting that other determinants in the protein can
overcome the inhibitory effect caused by phosphoryla-
tion of ser482 and ser484 in vitro.
Our cellular experiments show that mutation of the
ﬁve phosphorylation sites within the WAVE2 A domain
generate a protein with properties resembling the DVCA
mutant more than the wild-type. In cases such as protru-
sion raggedness and persistence, the phenotypes are
more extreme for the 5A phospho-mutant than the
DVCA mutant. This may indicate that the 5A protein
is still able to bind actin and sequester it from other,
compensatory, nucleation pathways. The 5A phospho-
mutant VCA domain has a low afﬁnity for the Arp2/3
complex, and while this does not appear to be important
for the activity of the isolated VCA domain in vitro, it is
possible that a high afﬁnity is required to generate a
signiﬁcant concentration of a WAVE2/Arp2/3 complex
in vivo.
The loss of rufﬂes and the irregular protrusions
formed in scratch-wounding assays in the presence of
non-phosphorylatable WAVE2, suggest that phosphoryl-
ation of the WAVE2 VCA domain is crucial for normal
WAVE2 function. In particular the ragged leading edges
of scratch-wound cells suggest that the integrity of cell
protrusion is compromised. This could potentially be
explained by disrupted lamellipodium formation as
would be expected in a cell lacking functional WAVE2
[Kunda et al., 2003; Yan et al., 2003]. This may in turn
explain the loss of persistent migration, another pheno-
type observed in WAVE2 depleted cells [Danson et al.,
2007].
CONCLUSIONS
The questions remain as to the nature of the regula-
tion of these phosphorylation events. It appears that
phosphorylation is constitutive and not signal dependent,
although there may well be stimuli/cellular events that
trigger dephosphorylation that we have not yet identiﬁed.
Bearing in mind the impact of phosphorylations on VCA
domain function it is interesting to note the number of
sites in various WASP/WAVE family members -
WASP/N-WASP have two sites, WAVE2 has ﬁve sites
only three of which are found in WAVE1 and four of
which in WAVE3. Could phosphorylation of the VCA
domain be a way of introducing distinct levels of activity
and functions of the distinct isoforms?
REFERENCES
Ardern H, Sandilands E, Machesky LM, Timpson P, Frame MC,
Brunton VG. 2006. Src-dependent phosphorylation of Scar1
promotes its association with the Arp2/3 complex. Cell Motil
Cytoskeleton 63(1):6–13.
Beltzner CC, Pollard TD. 2008. Pathway of actin ﬁlament branch for-
mation by Arp2/3 complex. J Biol Chem 283(11):7135–7144.
Cory GO, Cramer R, Blanchoin L, Ridley AJ. 2003. Phosphorylation
of the WASP-VCA domain increases its afﬁnity for the Arp2/3
complex and enhances actin polymerization by WASP. Mol
Cell 11(5):1229–1239.
Danson CM, Pocha SM, Bloomberg GB, Cory GO. 2007. Phosphoryl-
ation of WAVE2 by MAP kinases regulates persistent cell
migration and polarity. J Cell Sci 120 (Part 23):4144–4154.
Goley ED, Rodenbusch SE, Martin AC, Welch MD. 2004. Critical
conformational changes in the Arp2/3 complex are induced by
nucleotide and nucleation promoting factor. Mol Cell
16(2):269–279.
Ibarra N, Pollitt A, Insall RH. 2005. Regulation of actin assembly by
SCAR/WAVE proteins. Biochem Soc Trans 33 (Part 6):1243–
1246.
Kelly AE, Kranitz H, Dotsch V, Mullins RD. 2006. Actin binding to
the central domain of WASP/Scar proteins plays a critical role
in the activation of the Arp2/3 complex. J Biol Chem
281(15):10589–10597.
Kim Y, Sung JY, Ceglia I, Lee KW, Ahn JH, Halford JM, Kim AM,
Kwak SP, Park JB, Ho Ryu S, Schenck A, Bardoni B, Scott JD,
46 Pocha and Cory
Nairn AC, Greengard P. 2006. Phosphorylation of WAVE1
regulates actin polymerization and dendritic spine morphology.
Nature 442(7104):814–817.
Kuenzel EA, Mulligan JA, Sommercorn J, Krebs EG. 1987. Substrate
speciﬁcity determinants for casein kinase II as deduced from
studies with synthetic peptides. J Biol Chem 262(19):9136–
9140.
Kunda P, Craig G, Dominguez V, Baum B. 2003. Abi, Sra1, and Kette
control the stability and localization of SCAR/WAVE to regu-
late the formation of actin-based protrusions. Curr Biol 13(21):
1867–1875.
Leng Y, Zhang J, Badour K, Arpaia E, Freeman S, Cheung P, Siu M,
Siminovitch K. 2005. Abelson-interactor-1 promotes WAVE2
membrane translocation and Abelson-mediated tyrosine phos-
phorylation required for WAVE2 activation. Proc Natl Acad
Sci USA 102(4):1098–1103.
Machesky LM, Mullins RD, Higgs HN, Kaiser DA, Blanchoin L, May
RC, Hall ME, Pollard TD. 1999. Scar, a WASp-related pro-
tein, activates nucleation of actin ﬁlaments by the Arp2/3 com-
plex. Proc Natl Acad Sci USA 96(7):3739–3744.
Magdalena J, Millard TH, Etienne-Manneville S, Launay S, Warwick
HK, Machesky LM. 2003. Involvement of the Arp2/3 complex
and Scar2 in Golgi polarity in scratch wound models. Mol Biol
Cell 14(2):670–684.
Marchand JB, Kaiser DA, Pollard TD, Higgs HN. 2001. Interaction of
WASP/Scar proteins with actin and vertebrate Arp2/3 complex.
Nat Cell Biol 3(1):76–82.
Meggio F, Pinna LA. 2003. One-thousand-and-one substrates of pro-
tein kinase CK2? FASEB J 17(3):349–368.
Nakanishi O, Suetsugu S, Yamazaki D, Takenawa T. 2007. Effect of
WAVE2 phosphorylation on activation of the Arp2/3 complex.
J Biochem (Tokyo). 141(3):319–325.
Panchal SC, Kaiser DA, Torres E, Pollard TD, Rosen MK. 2003. A
conserved amphipathic helix in WASP/Scar proteins is essen-
tial for activation of Arp2/3 complex. Nat Struct Biol
10(8):591–598.
Pollard TD. 2007. Regulation of actin ﬁlament assembly by arp2/3 com-
plex and formins. Annu Rev Biophys Biomol Struct 36:451–477.
Ridley AJ. 2006. Rho GTPases and actin dynamics in membrane protru-
sions and vesicle trafﬁcking. Trends Cell Biol 16(10):522–529.
Robinson RC, Turbedsky K, Kaiser DA, Marchand JB, Higgs HN,
Choe S, Pollard TD. 2001. Crystal structure of Arp2/3 com-
plex. Science 294(5547):1679–1684.
Rodal AA, Sokolova O, Robins DB, Daugherty KM, Hippenmeyer S,
Riezman H, Grigorieff N, Goode BL. 2005. Conformational
changes in the Arp2/3 complex leading to actin nucleation. Nat
Struct Mol Biol 12(1):26–31.
Shaul YD, Seger R. 2007. The MEK/ERK cascade: From signaling
speciﬁcity to diverse functions. Biochim Biophys Acta
1773(8):1213–1226.
Suetsugu S, Yamazaki D, Kurisu S, Takenawa T. 2003. Differential
roles of WAVE1 and WAVE2 in dorsal and peripheral rufﬂe
formation for ﬁbroblast cell migration. Dev Cell 5(4):595–609.
Yan C, Martinez-Quiles N, Eden S, Shibata T, Takeshima F, Shinkura R,
Fujiwara Y, Bronson R, Snapper SB, Kirschner MW, Geha R,
Rosen FS, Alt FW. 2003. WAVE2 deﬁciency reveals distinct
roles in embryogenesis and Rac-mediated actin-based motility.
EMBO J 22(14):3602–3612.
Phospho-Regulation of the WAVE2 VCA Domain 47
